We first evaluated the expression of the different PRDM2 transcripts by in silico analysis of TCGA-COAD (colon adenocarcinoma) datasets on GEPIA2 (Additional file 2: Fig S1) [16, 17]. Here, PRDM2 is linked to colon adenocarcinoma.